Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) Operating Expenses (2020 - 2026)

Trulieve Cannabis has reported Operating Expenses over the past 6 years, most recently at $159.9 million for Q4 2025.

  • For Q4 2025, Operating Expenses fell 13.91% year-over-year to $159.9 million; the TTM value through Dec 2025 reached $567.7 million, down 8.14%, while the annual FY2025 figure was $567.7 million, 8.14% down from the prior year.
  • Operating Expenses for Q4 2025 was $159.9 million at Trulieve Cannabis, up from $127.6 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $432.9 million in Q2 2023 and troughed at $62.7 million in Q1 2021.
  • A 5-year average of $150.0 million and a median of $137.5 million in 2022 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: soared 205.1% in 2023 and later tumbled 69.53% in 2024.
  • Year by year, Operating Expenses stood at $144.0 million in 2021, then increased by 5.51% to $151.9 million in 2022, then dropped by 17.93% to $124.7 million in 2023, then surged by 48.96% to $185.7 million in 2024, then dropped by 13.91% to $159.9 million in 2025.
  • Business Quant data shows Operating Expenses for TCNNF at $159.9 million in Q4 2025, $127.6 million in Q3 2025, and $130.3 million in Q2 2025.